| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-04-14 | Xiapex® (EU)/ Xiaflex® (USA) (collagenase clostridium histolyticum) | Peyronie\'s disease |
Auxilium Therapeutics (USA) Swedish Orphan Biovitrum (Sobi) (Sweden) | ||
| 2014-04-14 | ODM-201 | prostate cancer | 1-2 | Orion Corporation (Finland) | Cancer - Oncology |
| 2014-04-14 | VLX600 | 1-2 | Vivolux (Sweden) | Cancer - Oncology | |
| 2014-04-14 | CYT003 | allergic asthma |
2b | Cytos Biotechnology (Switzerland) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2014-04-14 | tepotinib | hepatocellular carcinoma | 1-2 | Merck KGaA (Germany) | Cancer - Oncology |
| 2014-04-11 | Favolir | asthma |
Vectura (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases | |
| 2014-04-11 | A4250 | Albireo (Sweden) | Metabolic diseases - Liver diseases | ||
| 2014-04-10 | BL-8040 | chronic myeloid leukemia |
1-2 | BioLineRx (Israel) | Cancer - Oncology |
| 2014-04-10 | Eloctate® (long-lasting recombinant Factor VIII Fc fusion protein - rFVIIIFc) | hemophilia A | pediatric study | BiogenIdec (USA) Swedish Orphan Biovitrum - SOBI (Sweden) | Hematological diseases - Genetic diseases |
| 2014-04-10 | aganirsen | psoriasis |
2a | Gene Signal (Switzerland) | Autoimmune diseases - Dermatological diseases |
| 2014-04-09 | ultra-fast acting formulation of insulin Lispro (Humalog®, Eli Lilly) | diabetes |
2a | Adocia (France) | Metabolic diseases |
| 2014-04-08 | AMG 232 in combination with trametinib and dabrafenib | melanoma | 1-2 | Amgen (USA - CA) | Cancer - Oncology |
| 2014-04-07 | Micropump® technology applied to sodium oxybate | narcolepsy |
1 | Flamel Technologies (France) | Neurological diseases |
| 2014-04-07 | BAL101553 | breast cancer | preclinical | Basilea Pharmaceutica (Switzerland) | Cancer - Oncology |
| 2014-04-07 | EGF816 (nazartinib) | advanced non-small cell lung cancer | 1-2 | Novartis (Switzerland) | Cancer - Oncology |
| 2014-04-07 | OTX015 | 1 | OncoEthix (Switzerland) | Cancer - Oncology | |
| 2014-04-07 | TNF-Kinoid | rheumatoid arthritis |
2b | Neovacs (France) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2014-04-07 | BIND-014 (docetaxel encapsulated in a polymeric nanoparticle) | metastatic cancer, solid tumors | 1 | Bind Therapeutics (USA - MA) | Cancer - Oncology |
| 2014-04-04 | emapticap pegol (anti-CCL2/MCP-1 Spiegelmer® NOX-E36 (Spiegelmers are the chemically synthesized, nonimmunogenic alternative to antibodies.) | diabetic nephropathy |
2a | Noxxon Pharma (Germany) | Renal diseases - Metabolic diseases - Kidney diseases |
| 2014-04-04 | veliparib (ABT-888) | squamous non-small cell lung cancer (NSCLC) | 3 | Abbvie (USA - IL) | Cancer - Oncology |
